Clinical practice patterns and cost-effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients.

Fitzgibbons P, Washington MK, Murphy D
Cancer. 2010 116 (16): 3980-1; author reply 3981

PMID: 20564109 · DOI:10.1002/cncr.25186

MeSH Terms (7)

Biomarkers, Tumor Breast Neoplasms Cost-Benefit Analysis Female Humans Practice Patterns, Physicians' Receptor, ErbB-2

Connections (1)

This publication is referenced by other Labnodes entities: